DeepMed Research

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis

Conditions: Hepatocellular Carcinoma
Cirrhosis

Interventions: Other: Auto-pended bot liver ultrasound order

First Posted Date: 2024-10-02

Last Posted Date: 2025-04-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 600

Registration Number: NCT06624189

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening

Phase 4

Recruiting

Conditions: Attention-deficit/Hyperactivity Disorder

Interventions: Drug: Methylphenidate Hydrochloride Extended Release Capsule

First Posted Date: 2024-08-29

Last Posted Date: 2024-08-29

Lead Sponsor: NYU Langone Health

Target Recruit Count: 30

Registration Number: NCT06577779

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure

Not Applicable

Recruiting

Conditions: Graft Failure
Poor Graft Function

Interventions: Device: CD34+ Selected Donor Cell Boost
Procedure: Blood Stem Cell Infusion

First Posted Date: 2024-08-23

Last Posted Date: 2024-11-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 21

Registration Number: NCT06569082

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial

Phase 3

Not yet recruiting

Conditions: Coronary Artery Disease
Cognitive Impairment
Heart Failure

Interventions: Procedure: Guideline-directed medical therapy (GDMT)
Procedure: Percutaneous coronary intervention (PCI).
Procedure: Coronary artery bypass grafting (CABG)

First Posted Date: 2024-08-22

Last Posted Date: 2025-04-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 1200

Registration Number: NCT06566183

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States
🇵🇱
International Study Site, International Study Site, Poland

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

Recruiting

Conditions: Colorectal Cancer (Diagnosis)
Lung Cancer Diagnosis
Prostate Cancer Diagnosis
Breast Cancer Diagnosis

First Posted Date: 2024-08-19

Last Posted Date: 2024-11-04

Lead Sponsor: NYU Langone Health

Target Recruit Count: 1800

Registration Number: NCT06559059

Locations: 🇺🇸
VA New York Harbor Healthcare System - Brooklyn, Brooklyn, New York, United States
🇺🇸
VA New York Harbor Healthcare System - St. Albans Community Living Center, Jamaica, New York, United States
🇺🇸
VA New York Harbor Health Care System - Manhattan, New York, New York, United States

and more 2 locations

Scaling Telehealth Models to Improve Co-morbid Diabetes and Hypertension in Immigrant Populations (Phase II)

Not Applicable

Conditions: Hypertension
Diabetes Mellitus Type II

Interventions: Behavioral: Integrated CHW Intervention
Behavioral: CHW Session 1 Only

First Posted Date: 2024-08-07

Last Posted Date: 2025-01-07

Lead Sponsor: NYU Langone Health

Target Recruit Count: 450

Registration Number: NCT06542939

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy

Not Applicable

Recruiting

Conditions: Prostate Cancer

Interventions: Radiation: 1.5 T Elekta Unity MR-Linac system
Device: Hydrogel rectal spacer (SpaceOAR)

First Posted Date: 2024-08-07

Last Posted Date: 2025-04-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 91

Registration Number: NCT06542757

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Effect of Internal Brace on Outcomes Following ACL Reconstruction With BTB Autograft

Not Applicable

Recruiting

Conditions: ACL Reconstruction

Interventions: Device: Arthrex Internal Brace
Procedure: ACL Reconstruction

First Posted Date: 2024-08-07

Last Posted Date: 2025-04-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 90

Registration Number: NCT06542705

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Effect of Novel High Dissolving Transitional Foods

Not Applicable

Conditions: Craniofacial Surgery

Interventions: Dietary Supplement: High Dissolving Transitional Food

First Posted Date: 2024-07-26

Last Posted Date: 2024-08-12

Lead Sponsor: NYU Langone Health

Target Recruit Count: 160

Registration Number: NCT06522958

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Pilot Subsidized and Culturally-adapted Community Supported Agriculture (CSA) Program

Not Applicable

Completed

Conditions: Diet Habit

Interventions: Behavioral: CSA model

First Posted Date: 2024-07-26

Last Posted Date: 2024-07-26

Lead Sponsor: NYU Langone Health

Target Recruit Count: 38

Registration Number: NCT06521411

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy